EUVIMEDEUVIMED entdecken
Crossref

Undertreatment or Overtreatment in the Adjuvant Setting for M1 No Evidence of Disease in Renal Cell Carcinoma: A Clinical Conundrum

Wesley Yip, Brian I Rini

European Urology Focus · 2025

DOI: 10.1016/j.euf.2025.04.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Urology Focus, 2025. Verfasst von Wesley Yip und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology and Urologic Oncology, City of Hope National Medical Center, Duarte, CA, USA. Electronic address: wyip@coh.org. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Overtreatment, Antibodies, Monoclonal, Humanized. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guidelines recommend consideration of 1 yr of adjuvant pembrolizumab for selected patients with oligometastatic renal cell carcinoma who are disease-free after metastasectomy. Owing to the heterogeneity of this population, it is unclear whether patients would benefit more from single-agent pembrolizumab or from observation and salvage therapy with multiagent regimens. Better prognostic biomarkers are needed to guide treatment decisions in this setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsOvertreatmentAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalHumansChemotherapy, AdjuvantUndertreatment

Substanzen

pembrolizumabAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Division of Urology and Urologic Oncology, City of Hope National Medical Center, Duarte, CA, USA. Electronic address: wyip@coh.org.
  • Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

Zitieren

APA

Yip, W., & Rini, B. I. (2025). Undertreatment or Overtreatment in the Adjuvant Setting for M1 No Evidence of Disease in Renal Cell Carcinoma: A Clinical Conundrum. European Urology Focus. https://doi.org/10.1016/j.euf.2025.04.009

Vancouver

Yip W, Rini BI. Undertreatment or Overtreatment in the Adjuvant Setting for M1 No Evidence of Disease in Renal Cell Carcinoma: A Clinical Conundrum. European Urology Focus. 2025. doi:10.1016/j.euf.2025.04.009

BibTeX
@article{Yip2025,
  author = {Yip, Wesley and Rini, Brian I},
  title = {Undertreatment or Overtreatment in the Adjuvant Setting for M1 No Evidence of Disease in Renal Cell Carcinoma: A Clinical Conundrum},
  journal = {European Urology Focus},
  year = {2025},
  doi = {10.1016/j.euf.2025.04.009}
}
Kostenlos starten →